Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Short term Debt (2023 - 2026)

Cannabis Bioscience International Holdings filings provide 4 years of Short term Debt readings, the most recent being $14592.0 for Q1 2026.

  • On a quarterly basis, Short term Debt fell 80.07% to $14592.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $14592.0, a 80.07% decrease, with the full-year FY2025 number at $14592.0, changed N/A from a year prior.
  • Short term Debt reached $14592.0 in Q1 2026 per CBIH's latest filing, roughly flat from $14592.0 in the prior quarter.
  • The five-year high for Short term Debt was $73228.0 in Q1 2025, with the low at $7054.0 in Q1 2024.
  • A 4-year average of $19152.8 and a median of $14592.0 in 2023 define the central range for Short term Debt.
  • Year-over-year, Short term Debt soared 938.11% in 2025 and then crashed 80.07% in 2026.
  • Year by year, Short term Debt stood at $12079.0 in 2023, then increased by 20.8% to $14592.0 in 2024, then changed by 0.0% to $14592.0 in 2025, then changed by 0.0% to $14592.0 in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Short term Debt are $14592.0 (Q1 2026), $14592.0 (Q4 2025), and $14592.0 (Q2 2025).